Skip to content
About
Management
Board of Directors
Scientific Advisory Board
Therapeutic Areas
Pipeline
OLX07010 in Rare Tauopathies
OLX07010 Alzheimer’s
Technology
MOA
Patents
News & Publications
Partners and Collaborators
Contact Us
Menu
Fighting Neurodegeneration with Tau Tangle Blocking: Oligomerix CEO James Moe Explains
Home
>
News
>
Fighting Neurodegeneration with Tau Tangle Blocking: Oligomerix CEO James Moe Explains
Print
Oligomerix
>
News
>
Fighting Neurodegeneration with Tau Tangle Blocking: Oligomerix CEO James Moe Explains
Fighting Neurodegeneration with Tau Tangle Blocking: Oligomerix CEO James Moe Explains
Post navigation
Previous Post
Oligomerix to Present at Clinical Trials on Alzheimer’s Disease Conference & Life Sciences Summit
Next Post
Oligomerix to Present at Upcoming Life Sciences Conferences
vera
View posts by vera
Leave a Reply
Cancel reply
You must be
logged in
to post a comment.
Scroll to top
close ×
